The Canadian Nosocomial Infection Surveillance Program (CNISP)
Healthcare-acquired infections (HAIs), also known as nosocomial infections, are infectious diseases acquired in health care facilities such as hospitals. Many HAIs are caused by antimicrobial-resistant organisms (AROs), such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). The Canadian Nosocomial Infection Surveillance Program (CNISP) is a sentinel surveillance system which collects epidemiologic and linked microbiology data from 90 Canadian acute-care hospitals across 10 provinces and two territories. CNISP summarizes trends in national incidence rates, antimicrobial resistance and molecular characterization for select HAIs and AROs.
The Canadian Nosocomial Infection Surveillance Program (CNISP) is a collaboration between the Public Health Agency of Canada (PHAC), including the National Microbiology Laboratory (NML), the Association of Medical Microbiology and Infectious Disease (AMMI) Canada, and acute-care hospitals across Canada.
Bed size and hospital type: Text Description
CNISP hospitals for 2022
The table below presents the participating CNISP hospitals across Canada for the year shown above. Use the dropdown in top right corner of the map to select the year of data you want the map and table to present. By using the free text search bar, you can search and filter the table for a specific hospital name, province, city, bed size or facility type. Single-click the column header to order the entries alphabetically in the selected column. Double-click the column header to order the entries in reverse alphabetical order in the selected column.
|Hospital Name||Province||City||Bed size||Facility Type|
CNISP Surveillance Protocols
Recent CNISP Publications
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2016–2020.
- Device and surgical procedure-related infections in Canadian acute-care hospitals from 2011 to 2020.
- Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017.
- Vancomycin-resistant Enterococcus sequence type 1478 spread across hospitals participating in the Canadian Nosocomial Infection Surveillance Program from 2013 to 2018.
- Patients in hospital with laboratory-confirmed COVID-19 in a network of Canadian acute care hospitals, Mar. 1 to Aug. 31, 2020: a descriptive analysis.
- Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.
- Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys.
- Response to Alert on Possible Infections with Mycobacterium chimaera From Contaminated Heater-Cooler Devices in Hospitals Participating in the Canadian Nosocomial Infection Surveillance Program (CNISP).
- The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015).
- Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019.
Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS)
Information on antimicrobial use and antimicrobial resistance in foodborne bacteria along the foodchain can be found on the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) website.
Healthcare infection prevention and control guidelines
Information on guidelines to help prevent the spread of infection in healthcare settings can be found on the Healthcare infection prevention and control guidelines website. These guidelines were developed by the Public Health Agency of Canada with the support of the National Advisory Committee on Infection Prevention and Control (NAC-IPC).
- Date modified: